- Home
- TALO vs TARS Comparison
TALO vs TARS Comparison
Compare TALO & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- TARS
- Stock Information
- Founded
- TALO 2011
- TARS 2016
- Country
- TALO United States
- TARS United States
- Employees
- TALO N/A
- TARS N/A
- Industry
- TALO Oil & Gas Production
- TARS Medicinal Chemicals and Botanical Products
- Sector
- TALO Energy
- TARS Health Care
- Exchange
- TALO Nasdaq
- TARS Nasdaq
- Market Cap
- TALO 1.5B
- TARS 1.7B
- IPO Year
- TALO N/A
- TARS 2020
- Fundamental
- Price
- TALO $9.88
- TARS $58.58
- Analyst Decision
- TALO Buy
- TARS Strong Buy
- Analyst Count
- TALO 7
- TARS 7
- Target Price
- TALO $14.29
- TARS $67.14
- AVG Volume (30 Days)
- TALO 2.7M
- TARS 663.8K
- Earning Date
- TALO 08-06-2025
- TARS 08-06-2025
- Dividend Yield
- TALO N/A
- TARS N/A
- EPS Growth
- TALO N/A
- TARS N/A
- EPS
- TALO N/A
- TARS N/A
- Revenue
- TALO $1,931,650,000.00
- TARS $295,521,000.00
- Revenue This Year
- TALO N/A
- TARS $33,170.29
- Revenue Next Year
- TALO N/A
- TARS N/A
- P/E Ratio
- TALO N/A
- TARS N/A
- Revenue Growth
- TALO 10.70
- TARS 254.45
- 52 Week Low
- TALO $6.23
- TARS $25.82
- 52 Week High
- TALO $12.71
- TARS $58.95
- Technical
- Relative Strength Index (RSI)
- TALO 70.50
- TARS 75.87
- Support Level
- TALO $9.49
- TARS $56.04
- Resistance Level
- TALO $9.87
- TARS $58.70
- Average True Range (ATR)
- TALO 0.33
- TARS 1.85
- MACD
- TALO 0.19
- TARS 0.32
- Stochastic Oscillator
- TALO 96.15
- TARS 96.11
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.